Use of nanoparticles, a modern means of drug delivery, against cryptosporidiosis
- PMID: 38370897
- PMCID: PMC10868694
- DOI: 10.5455/javar.2023.j726
Use of nanoparticles, a modern means of drug delivery, against cryptosporidiosis
Abstract
Cryptosporidium is a primary cause of waterborne epidemics, despite being previously considered only an opportunistic pathogen. The disease is associated with significant economic losses in humans and animals that are brought on by diarrhea, which frequently causes dehydration. Contact with diseased people or animals, as well as polluted water, is the major cause of infection. Different drugs are used to control the parasites. Nitazoxanide (NTZ), which is an anti-protozoan and anti-viral drug, can be used to control helminths, viruses, and protozoan parasites as a broad-spectrum antibiotic and has been approved by the food and drug authority (FDA). However, the problem is the development of resistance over a period of time in these parasites. Nanoparticles have received significant attention as possible anti-parasitic agents in recent years. By directing medications to specific cellular locations, targeted drug delivery minimizes the side effects of medications. Nanoparticles have demonstrated effectiveness against different Cryptosporidium species. Nanoparticles loaded with NTZ are found to be an effective remedy for C. parvum in young ones and decrease the oocyst count shed in the stools. Additionally, silver nanoparticles have proven to be effective against C. parvum by releasing silver ions that breach the cell wall of the oocyst, causing the escape of intracellular contents and the destruction of sporozoites within the oocyst. Implementing tiny particles for the purification of consuming water from Cryptosporidium is an economical and environmentally sustainable process. However, the use of nanoparticles in medicine requires more research.
Keywords: Cryptosporidium parvum; chitosan nanoparticles; nanoparticles; oocyst; silver nanoparticles; viability.
Copyright: © Journal of Advanced Veterinary and Animal Research.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Thymoquinone loaded on chitosan nanoparticles alleviated the consequences of cryptosporidiosis infection in a murine model: Evidence from parasitological, histopathological, immunohistochemical, and immunological studies.PLoS One. 2025 May 30;20(5):e0325077. doi: 10.1371/journal.pone.0325077. eCollection 2025. PLoS One. 2025. PMID: 40446176 Free PMC article.
-
Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect.Pharmaceutics. 2024 Jul 22;16(7):968. doi: 10.3390/pharmaceutics16070968. Pharmaceutics. 2024. PMID: 39065665 Free PMC article.
-
Molecular identification and antiprotozoal activity of silver nanoparticles on viability of Cryptosporidium parvum isolated from pigeons, pigeon fanciers and water.Sci Rep. 2023 Feb 22;13(1):3109. doi: 10.1038/s41598-023-30270-2. Sci Rep. 2023. PMID: 36813872 Free PMC article.
-
Drug treatment and novel drug target against Cryptosporidium.Parasite. 2008 Sep;15(3):275-81. doi: 10.1051/parasite/2008153275. Parasite. 2008. PMID: 18814694 Review.
-
Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst.Water Res. 2004 Feb;38(4):818-62. doi: 10.1016/j.watres.2003.10.012. Water Res. 2004. PMID: 14769405 Review.
References
-
- Fayer R. Taxonomy and species delimitation in Cryptosporidium. Exper Parasitol. 2010;124(1):90–97. https://doi.org/10.1016/j.exppara.2009.03.005. - PubMed
-
- Chen X, Saeed NM, Ding J, Dong H, Kulyar MF-E-A, Bhutta ZA, et al. Molecular epidemiological investigation of cryptosporidium sp., Giardia duodenalis, Enterocytozoon bieneusi and Blastocystis sp. Infection in Free-ranged Yaks and Tibetan Pigs on the Plateau. Pak Vet J. 2022;42(4):533–39. https://doi.org/10.29261/pakvetj/2022.060.
-
- Xuehan L, Lei D, Zhong Z, Ziyao Z, Xuefeng Y, Zhixing A. Identification of a New MLST subtype of cryptosporidium muris from a brown rat (Rattus norvegicus) in China. Kafkas Üniv Vetr Fakült Derg. 2021;27(3)
-
- Qi M, Wang R, Ning C, Li X, Zhang L, Jian F, et al. Cryptosporidium spp. in pet birds: genetic diversity and potential public health significance. Exper Parasitol. 2011;128(4):336–40. https://doi.org/10.1016/j.exppara.2011.04.003. - PubMed
-
- Liu X, He T, Zhong Z, Zhang H, Wang R, Dong H, et al. A new genotype of cryptosporidium from giant panda (Ailuropoda melanoleuca) in China. Parasitol Int. 2013;62(5):454–58. https://doi.org/10.1016/j.parint.2013.06.004. - PubMed
Publication types
LinkOut - more resources
Full Text Sources